FDA ramps up monitoring in high-risk areas following DEG-contamination deaths overseas
Regulatory NewsJoanne S. Eglovitch
APIsAudit/inspectionChemistry, Manufacturing and Controls (CMC)ComplianceGlobalNorth AmericaOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicySupply Chain Management